MENLO PARK, Calif., April 4, 2018 /PRNewswire/ — Regenerative Patch Technologies LLC, a biotechnology company focused on the development of cell-based implant technology for the treatment of retinal diseases announced the publication of preliminary results from its Phase 1/2a clinical…